Get to know BioNTech
Biopharmaceutical New Technologies (BioNTech) is a global, next generation immunotherapy company pioneering novel, investigative therapies for cancer and other serious diseases. With a steadfast commitment to scientific rigor and operational excellence, BioNTech exploits a wide array of computational discovery and therapeutic modalities with the intent to rapidly develop novel biopharmaceuticals. The company’s diversified portfolio aims to address the full continuum of cancer with oncology product candidates, including mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies such as antibody-drug conjugates (ADCs) and innovative chimeric antigen receptor (CAR) T cell therapies. Leveraging key capabilities in mRNA research and development, in-house manufacturing, immunology, deep genomics and AI, BioNTech and its collaborators are researching and developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline.
Annual report
Reflecting on the achievements of 2025, our guiding motto for this year’s annual report, “Momentum”, encapsulates the progress that defined the past year for us: We achieved key milestones that strengthened our position in oncology, validated our approaches with encouraging data, and set the stage for significant progress in 2026. Read more about those milestones in our report.
Download the 2025 annual report
18 MB / PDF
Explore more about BioNTech
Our board members
Meet the leaders driving our efforts to leverage the immune system to develop treatments for diseases with unmet and/or high medical need.
Our collaborators
Discover how our partnerships and collaborations with a number of the world’s most established biotechnology and pharmaceutical companies, academia and non-profit organizations help us drive medical breakthroughs and therapeutic innovations to improve standard of care.
Our sites and subsidiaries
BioNTech’s global site network integrates capabilities from discovery to delivery that fuel the research, development and commercialization of novel immunotherapies and vaccines.
Our corporate sustainability and responsibility
Find out how BioNTech’s commitment to innovation, transparency, and sustainability supports global health and responsible governance.
